Effect of erythropoietin on angiogenesis with the increased adhesion of platelets to the microvessels in the hind-limb ischemia model in mice

Journal of Pharmacological Sciences

Volumn 112, Issue 2, 2010, Pages 167-175

  Kato, Shintaro ^a   Amano, Hideki ^a   Ito, Yoshiya ^a   Eshima, Koji ^a   Aoyama, Naoyoshi ^a   Tamaki, Hideaki ^a   Sakagami, Hiroyuki ^a   Satoh, Yukitoshi ^a   Izumi, Toru ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Erythropoietin; Intravital microscopy; P selectin; Platelet

Indexed keywords

ERYTHROPOIETIN; NEUTRALIZING ANTIBODY; PADGEM PROTEIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DOSE RESPONSE; FEMORAL ARTERY; FLOW CYTOMETRY; HIND LIMB ISCHEMIA; IN VIVO STUDY; ISCHEMIA; LIGATION; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; THROMBOCYTE ADHESION;

EID: 77249178869     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09262FP     Document Type: Article

References (25)

1. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003;102:1340-1346.
2. Peterson TE, Katusic ZS. EPO tecting the endothelium. Br J Pharmacol. 2007;150:823-825.
3. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115:3378-3384.
4. Pinedo HM, Verheul HM, D'Amato RJ, Folkman J. Involvement of platelet in tumor angiogenesis? Lancet. 1998;352:1775-1777.
5. Pipili-Synetos E, Papadimitriou E, Maragoudakis ME. Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol. 1998;125:1252-1257.
6. Amano H, Hackett NR, Rafii S, Crystal RG. Thrombopoietin gene transfer-mediated enhancement of angiogenic response to acute ischemia. Circ Res. 2005;97:337-345.
7. Iba O, Mastubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemia limbs. Circulation. 2002;106:2019-2025.
8. Kopp HG, Rafii S. Thrombopoietic cells and the bone marrow vascular niche. Ann N Y Acad Sci. 2007;106:175-179.
9. Kirkeby A, Torup L, Bochsen L, Kjalke M, Abel K, Theilgaard-Monch K, et al. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thromb Haemost. 2008;99:720-728.
10. Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood. 2000;95:2983-2989.
11. Sayinalp N, Erdem Y, Ilhami Ozcebe O, Büyükaşik Y, Caǧlar S, Dündar SV. Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients. Thromb Res. 1998;90:195-198.
12. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, et al. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest. 2004;114:784-794.
13. Heeschen C, Aicher A, Lehmann R, Fichtischerer S, Vasa M, Urbich C, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003;102: 1340-1346.
14. Bleuel H, Hoffmann R, Kaufmann B, Neubert P, Ochlich PP, Schaumann W. Kinetics of subcutaneous versus intraveneous epoetin-beta in dogs, rats and mice. Pharmacology. 1996;52: 329-338.
15. d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension. 2007;49: 1142-1148.
16. Egami K, Murohara T, Aoki M, Matsuishi T. Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin. J Leukoc Biol. 2006;79:971-976.
17. Langer H, Gawaz M. Platelets in regenerative medicine. Basic Res Cardiol. 2008;103:299-307.
18. Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A. 2006;103:855-860.
19. Xu T, Zhang L, Geng ZH, Wang HB, Wang JT, Chen M, et al. Pselectin cross-links PSGL-1 and enhances neutrophil adhesion to fibrinogen and ICAM-1 in a Src kinase-dependent, but GPCRindependent mechanism. Cell Adh Migr. 2007;1:115-123.
20. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28:299-307.
21. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107:1322-1328.
22. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med. 2006;12:557-567.
23. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Chadburn A, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001;7:1194-1202.
24. Massberg S, Konrad I, Schurgzinger K, Lorenz M, Schneider S, Zohlnhoefer D, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006;203:1221-1233.
25. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006;124:175-189.